MedTrace Logo

A Single and Multiple Ascending Dose Study of BMS-986318 in Healthy Participants

NCT04082741 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2020-01-27

No results posted yet for this study

Summary

A study to evaluate single and multiple ascending doses of experimental medicine BMS-986318 in healthy participants.

Conditions

  • Healthy Participants

Interventions

DRUG

BMS-986318

Specified dose on specified days

OTHER

Placebo

Placebo Matching BMS-986318

Sponsors & Collaborators

Principal Investigators

  • Bristol-Myers Squibb · Bristol-Myers Squibb

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-18
Primary Completion
2019-09-12
Completion
2019-09-12
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04082741 on ClinicalTrials.gov